Biomedical studies are including more female subjects (finally)
By Bethany Brookshire,
Science News
| 06. 09. 2020
In 2019, 49 percent of biomedical research articles had both male and female subjects, almost double the percentage a decade years ago.
Biomedical science has historically been a male-dominated world — not just for the scientists, but also for their research subjects. Even most lab mice were male (SN: 6/18/19). But now, a new study shows that researchers are starting to include more females — from mice to humans — in their work.
In 2019, 49 percent of articles surveyed in biomedical science used both male and female subjects, almost twice as many as a decade before, according to findings published June 9 in eLife.
A study of articles published in 2009 across 10 biomedical disciplines showed a dismal picture. Only 28 percent of 841 research studies included both males and female subjects. The results were published in 2011 in Neuroscience and Biobehavioral Reviews.
The scientific world took note. In 2016, the U.S. National Institutes of Health instituted the Sex as a Biological Variable policy in an effort to correct the imbalance. Scientists had to use both males and females in NIH-funded research unless they could present a “strong justification” otherwise.
Annaliese Beery, a neuroscientist at Smith...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...